Clinical Trial Update: Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain [Phase 2]

View source ↗

Summary

Phase 2 trial of Namisol (Delta-9-tetrahydrocannabinol) for chronic pancreatitis with persistent abdominal pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Pancreatitis

Drugs mentioned

• Namisol

Snippet

Sponsor: Radboud University Medical Center | Conditions: Pancreatitis, Chronic, Abdominal Pain | Phase 2 | Status: COMPLETED